Search research articles
Contact Us
Filters
Showing results (121-130 of 203) with videos related to
Page
of 21
Sort By:
Journal of Clinical Psychopharmacology
|
April 22, 2011
Predicting dopamine D₂ receptor occupancy from plasma levels of antipsychotic drugs: a systematic review and pooled analysis
Hiroyuki Uchida, Hiroyoshi Takeuchi, Ariel Graff-Guerrero, et al.
The Journal of Clinical Psychiatry
|
May 3, 2016
Quantifying intraindividual variations in plasma clozapine levels: a population pharmacokinetic approach
Jimmy Lee, Robert Bies, Hiroyoshi Takeuchi, et al.
Journal of Psychiatric Research
|
February 12, 2026
Parenting style and deliberate self-harm among children and adolescents: A hospital-based case-control study in Japan
Yoshikazu Komura, Saiko Ema, Nobuyuki Nomura, et al.
The Journal of Clinical Psychiatry
|
January 20, 2025
Effects of Intravenous Hydroxyzine Versus Haloperidol Monotherapy for Delirium: A Retrospective Study
Kaoruhiko Kubo, Moe Takehara, Mayuko Hirata, et al.
Psychiatry and Clinical Neurosciences
|
April 8, 2026
Time-dependent risk of falls associated with hypnotic use in hospitalized patients
Kazuhiro Shishida, Yutaro Shimomura, Masayuki Murayama, et al.
The Journal of Clinical Psychiatry
|
February 27, 2014
Impact of once- versus twice-daily perphenazine dosing on clinical outcomes: an analysis of the CATIE data
Hiroyoshi Takeuchi, Gagan Fervaha, Hiroyuki Uchida, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
December 6, 2018
Does relapse contribute to treatment resistance? Antipsychotic response in first- vs. second-episode schizophrenia
Hiroyoshi Takeuchi, Cynthia Siu, Gary Remington, et al.
The Journal of Clinical Psychiatry
|
August 8, 2014
Dose reduction of risperidone and olanzapine and estimated dopamine D₂ receptor occupancy in stable patients with schizophrenia: findings from an open-label, randomized, controlled study
Hiroyoshi Takeuchi, Takefumi Suzuki, Robert R Bies, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
January 9, 2015
Antipsychotics and amotivation
Gagan Fervaha, Hiroyoshi Takeuchi, Jimmy Lee, et al.
Human Psychopharmacology
|
July 9, 2021
Pharmacological treatment algorithms for the acute phase, agitation, and maintenance phase of first-episode schizophrenia: Japanese Society of Clinical Neuropsychopharmacology treatment algorithms
Hiroyoshi Takeuchi, Yoshiteru Takekita, Hikaru Hori, et al.
Page
of 21
Search research articles
Search
Showing results (121-130 of 203) with videos related to
Sort By:
Page
of 21
Journal of Clinical Psychopharmacology
|
April 22, 2011
Predicting dopamine D₂ receptor occupancy from plasma levels of antipsychotic drugs: a systematic review and pooled analysis
Hiroyuki Uchida, Hiroyoshi Takeuchi, Ariel Graff-Guerrero, et al.
The Journal of Clinical Psychiatry
|
May 3, 2016
Quantifying intraindividual variations in plasma clozapine levels: a population pharmacokinetic approach
Jimmy Lee, Robert Bies, Hiroyoshi Takeuchi, et al.
Journal of Psychiatric Research
|
February 12, 2026
Parenting style and deliberate self-harm among children and adolescents: A hospital-based case-control study in Japan
Yoshikazu Komura, Saiko Ema, Nobuyuki Nomura, et al.
The Journal of Clinical Psychiatry
|
January 20, 2025
Effects of Intravenous Hydroxyzine Versus Haloperidol Monotherapy for Delirium: A Retrospective Study
Kaoruhiko Kubo, Moe Takehara, Mayuko Hirata, et al.
Psychiatry and Clinical Neurosciences
|
April 8, 2026
Time-dependent risk of falls associated with hypnotic use in hospitalized patients
Kazuhiro Shishida, Yutaro Shimomura, Masayuki Murayama, et al.
The Journal of Clinical Psychiatry
|
February 27, 2014
Impact of once- versus twice-daily perphenazine dosing on clinical outcomes: an analysis of the CATIE data
Hiroyoshi Takeuchi, Gagan Fervaha, Hiroyuki Uchida, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
December 6, 2018
Does relapse contribute to treatment resistance? Antipsychotic response in first- vs. second-episode schizophrenia
Hiroyoshi Takeuchi, Cynthia Siu, Gary Remington, et al.
The Journal of Clinical Psychiatry
|
August 8, 2014
Dose reduction of risperidone and olanzapine and estimated dopamine D₂ receptor occupancy in stable patients with schizophrenia: findings from an open-label, randomized, controlled study
Hiroyoshi Takeuchi, Takefumi Suzuki, Robert R Bies, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
January 9, 2015
Antipsychotics and amotivation
Gagan Fervaha, Hiroyoshi Takeuchi, Jimmy Lee, et al.
Human Psychopharmacology
|
July 9, 2021
Pharmacological treatment algorithms for the acute phase, agitation, and maintenance phase of first-episode schizophrenia: Japanese Society of Clinical Neuropsychopharmacology treatment algorithms
Hiroyoshi Takeuchi, Yoshiteru Takekita, Hikaru Hori, et al.
Page
of 21